Vanillic acid inhibits inflammatory mediators by suppressing NF-κB in lipopolysaccharide-stimulated mouse peritoneal macrophages

Immunopharmacology and Immunotoxicology

Volumn 33, Issue 3, 2011, Pages 525-532

  Kim, Min Cheol ^a   Kim, Su Jin ^b   Kim, Dae Seung ^a   Jeon, Yong Deok ^a   Park, Sung Joo ^c   Lee, Ho Sub ^c   Um, Jae Young ^b   Hong, Seung Heon ^a  

^a Wonkwang University   (South Korea)

^b Kyung Hee University   (South Korea)

^c Wonkwang University   (South Korea)

Author keywords

caspase 1; inflammation; interleukin 6; nuclear factor kappa B; tumor necrosis factor ; Vanillic acid

Indexed keywords

CYCLOOXYGENASE 2; CYTOKINE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 1BETA CONVERTING ENZYME; INTERLEUKIN 6; LIPOPOLYSACCHARIDE; NITRIC OXIDE; PROSTAGLANDIN E2; TUMOR NECROSIS FACTOR ALPHA; VANILLIC ACID;

ANIMAL CELL; ANIMAL EXPERIMENT; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CYTOKINE PRODUCTION; ENZYME ACTIVATION; ENZYME DEGRADATION; MALE; MOUSE; NONHUMAN; PERITONEUM MACROPHAGE; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ANIMALS; ANTI-INFLAMMATORY AGENTS; CASPASE 1; CYCLOOXYGENASE 2; DINOPROSTONE; INFLAMMATION; INFLAMMATION MEDIATORS; INTERLEUKIN-6; LIPOPOLYSACCHARIDES; MACROPHAGES, PERITONEAL; MALE; MICE; MICE, INBRED C57BL; NF-KAPPA B; NITRIC OXIDE; TUMOR NECROSIS FACTOR-ALPHA; VANILLIC ACID;

EID: 79961158120     PISSN: 08923973     EISSN: 15322513     Source Type: Journal    
DOI: 10.3109/08923973.2010.547500     Document Type: Article

References (52)

1. Medzhitov, R., Janeway, C.A., Jr. Innate immunity: the virtues of a nonclonal system of recognition. Cell 1997, 91, 295-298. (Pubitemid 27467959)
2. Beutler, B. Tlr4: central component of the sole mammalian LPS sensor. Curr. Opin. Immunol. 2000, 12, 20-26. (Pubitemid 30093446)
3. Beutler, B. TNF, immunity and infammatory disease: lessons of the past decade. J. Investig. Med. 1995, 43, 227-235.
4. Parrillo, J.E. Pathogenetic mechanisms of septic shock. N. Engl. J. Med. 1993, 328, 1471-1477.
5. Vane, J.R., Botting, R.M. Anti-infammatory drugs and their mechanism of action. Infamm. Res. 1998, 47, 578-587.
6. Morita, I.M., Schindler, M.K., Regier, J.C., Otto, T., Hori, D.L., KeWitt, Smith W.L. Diferent intracellular locations for prostaglandin endoperoxide H synthase-1 and-2. J. Biol. Chem. 1995, 270, 10902-10908.
7. Otto, J.C., Smith, W.L. Prostaglandin endoperoxide synthases-1 and-2. J. Lipid Mediat. Cell Signal. 1995, 12, 139-156.
8. MacMicking, J., Xie, Q.W., Nathan, C. Nitric oxide and macrophage function. Annu. Rev. Immunol. 1997, 15, 323-350. (Pubitemid 27169284)
9. Pfeilschifter, J., Mühl, H. Immunopharmacology: anti-infammatory therapy targeting transcription factors. Eur. J. Pharmacol. 1999, 375, 237-245. (Pubitemid 29317608)
10. Sharma, J.N., Al-Omran, A., Parvathy, S.S. Role of nitric oxide in infammatory diseases. Infammopharmacology 2007, 15, 252-259. (Pubitemid 351196133)
11. Tegeder, I., Pfeilschifter, J., Geisslinger, G. Cyclooxygenase- independent actions of cyclooxygenase inhibitors. FASEB J. 2001, 15, 2057-2072. (Pubitemid 32927924)
12. Ghosh, S., May, M.J., Kopp, E.B. NF-kappa B and Rel proteins: evolutionarily conserved mediators of immune responses. Annu. Rev. Immunol. 1998, 16, 225-260. (Pubitemid 28183365)
13. Tanos, D., Maniatis, T. NF-kappa B: a lesson in family values. Cell 1995, 80, 529-532.
14. Baeuerle, P.A., Henkel, T. Function and activation of NF-kappa B in the immune system. Annu. Rev. Immunol. 1994, 12, 141-179.
15. Baldwin, A.S., Jr. Te NF-kappa B and I kappa B proteins: new discoveries and insights. Annu. Rev. Immunol. 1996, 14, 649-683. (Pubitemid 26130197)
16. Finco, T.S., Baldwin, A.S. Mechanistic aspects of NF-kappa B regulation: the emerging role of phosphorylation and proteolysis. Immunity 1995, 3, 263-272.
17. Lee, S.H., Stehlik, C., Reed, J.C. Cop, a caspase recruitment domain-containing protein and inhibitor of caspase-1 activation processing. J. Biol. Chem. 2001, 276, 34495-34500.
18. Wang, X., Wang, H., Figueroa, B.E., Zhang, W.H., Huo, C., Guan, Y., Zhang, Y., Bruey, J.M., Reed, J.C., Friedlander, R.M. Dysregulation of receptor interacting protein-2 and caspase recruitment domain only protein mediates aberrant caspase-1 activation in Huntington's disease. J. Neurosci. 2005, 25, 11645-11654. (Pubitemid 43098457)
19. Druilhe, A., Srinivasula, S.M., Razmara, M., Ahmad, M., Alnemri, E.S. Regulation of IL-1beta generation by pseudo-ICE and ICEBERG, two dominant negative caspase recruitment domain proteins. Cell Death Difer. 2001, 8, 649-657. (Pubitemid 32586602)
20. Srinivasula, S.M., Poyet, J.L., Razmara, M., Datta, P., Zhang, Z., Alnemri, E.S. Te PYRIN-CARD protein ASC is an activating adaptor for caspase-1. J. Biol. Chem. 2002, 277, 21119-21122. (Pubitemid 34952246)
21. Stehlik, C., Lee, S.H., Dorfeutner, A., Stassinopoulos, A., Sagara, J., Reed, J.C. Apoptosis-associated speck-like protein containing a caspase recruitment domain is a regulator of procaspase-1 activation. J. Immunol. 2003, 171, 6154-6163. (Pubitemid 37467238)
22. Mariathasan, S., Newton, K., Monack, D.M., Vucic, D., French, D.M., Lee, W.P., Roose-Girma, M., Erickson, S., Dixit, V.M. Diferential activation of the infammasome by caspase-1 adaptors ASC and Ipaf. Nature 2004, 430, 213-218. (Pubitemid 38902430)
23. Jason, G.W., Pajurkova, E.M., Suchowersky, O., Hewitt, J., Hilbert, C., Reed, J., Hayden, M.R. Presymptomatic neuropsychological impairment in Huntington's disease. Arch. Neurol. 1998, 45, 769-773.
24. Poyet, J.L., Srinivasula, S.M., Tnani, M., Razmara, M., Fernandes-Alnemri, T., Alnemri, E.S. Identifcation of Ipaf, a human caspase-1-activating protein related to Apaf-1. J. Biol. Chem. 2001, 276, 28309-28313.
25. Faubel, S., Lewis, E.C., Reznikov, L., Ljubanovic, D., Hoke, T.S., Somerset, H., Oh, D.J., Lu, L., Klein, C.L., Dinarello, C.A., Edelstein, C.L. Cisplatin-induced acute renal failure is associated with an increase in the cytokines interleukin (IL)-1beta, IL-18, IL-6, and neutrophil infltration in the kidney. J. Pharmacol. Exp. Ter. 2007, 322, 8-15. (Pubitemid 46956357)
26. Lesage-Meessen, L., Delattre, M., Haon, M., Tibault, J.F., Ceccaldi, B.C., Brunerie, P., Asther, M. A two-step bioconversion process for vanillin production from ferulic acid combining Aspergillus niger and Pycnoporus cinnabarinus. J. Biotechnol. 1996, 50, 107-113. (Pubitemid 26319728)
27. Civolani, C., Barghini, P., Roncetti, A.R., Ruzzi, M., Schiesser, A. Bioconversion of ferulic acid into vanillic acid by means of a vanillate-negative mutant of Pseudomonas fuorescens strain BF13. Appl. Environ. Microbiol. 2000, 66, 2311-2317. (Pubitemid 30353931)
28. Duke, J.A. Handbook of Phytochemical Constituents of GRAS Herbs and Other Economic Plants. Boca Raton, FL: CRC Press 1992, 999th edition. Available online at: http://www.ars-grin.gov/cgi-bin/duke
29. Narumi, S., Finke, J.H., Hamilton, T.A. Interferon gamma and interleukin 2 synergize to induce selective monokine expression in murine peritoneal macrophages. J. Biol. Chem. 1990, 265, 7036-7041.
30. Kim, M.S., Lim, W.K., Cha, J.G., An, N.H., Yoo, S.J., Park, J.H., Kim, H.M., Lee, Y.M. Te activation of PI 3-K and PKC zeta in PMA-induced diferentiation of HL-60 cells. Cancer Lett. 2001, 171, 79-85.
31. Schoonbroodt, S., Legrand-Poels, S., Best-Belpomme, M., Piette, J. Activation of the NF-kappaB transcription factor in a T-lymphocytic cell line by hypochlorous acid. Biochem. J. 1997, 321 (Pt 3), 777-785. (Pubitemid 27084888)
32. Kang, K.S., Yokozawa, T., Kim, H.Y., Park, J.H. Study on the nitric oxide scavenging efects of ginseng and its compounds. J. Agric. Food Chem. 2006, 54, 2558-2562.
33. Inbaraj, B.S., Lu, H., Kao, T.H., Chen, B.H. Simultaneous determination of phenolic acids and favonoids in Lycium barbarum Linnaeus by HPLC-DAD-ESI-MS. J. Pharm. Biomed. Anal. 2010, 51, 549-556.
34. Levites, Y., Weinreb, O., Maor, G., Youdim, M.B., Mandel, S. Green tea polyphenol (-)-epigallocatechin-3-gallate prevents N-methyl-4-phenyl-1,2,3,6- tetrahydropyridine-induced dopaminergic neurodegeneration. J. Neurochem. 2001, 78, 1073-1082. (Pubitemid 32823156)
35. Gao, X., Xu, Y.X., Janakiraman, N., Chapman, R.A., Gautam, S.C. Immunomodulatory activity of resveratrol: suppression of lymphocyte proliferation, development of cell-mediated cytotoxicity, and cytokine production. Biochem. Pharmacol. 2001, 62, 1299-1308. (Pubitemid 33055634)
36. Aggarwal, S., Ichikawa, H., Takada, Y., Sandur, S.K., Shishodia, S., Aggarwal, B.B. Curcumin (diferuloylmethane) down-regulates expression of cell proliferation and antiapoptotic and metastatic gene products through suppression of IkappaBalpha kinase and Akt activation. Mol. Pharmacol. 2006, 69, 195-206. (Pubitemid 43048906)
37. Chiang, L.C., Ng, L.T., Chiang, W., Chang, M.Y., Lin, C.C. Immunomodulatory activities of favonoids, monoterpenoids, triterpenoids, iridoid glycosides and phenolic compounds of Plantago species. Planta Med. 2003, 69, 600-604. (Pubitemid 37041053)
38. Aziz, N.H., Farag, S.E., Mousa, L.A., Abo-Zaid, M.A. Comparative antibacterial and antifungal efects of some phenolic compounds. Microbios 1998, 93, 43-54. (Pubitemid 128549359)
39. Guimarães, C.M., Gião, M.S., Martinez, S.S., Pintado, A.I., Pintado, M.E., Bento, L.S., Malcata, F.X. Antioxidant activity of sugar molasses, including protective efect against DNA oxidative damage. J. Food Sci. 2007, 72, C039-C043.
40. Kampa, M., Alexaki, V.I., Notas, G., Nifi, A.P., Nistikaki, A., Hatzoglou, A., Bakogeorgou, E., Kouimtzoglou, E., Blekas, G., Boskou, D., Gravanis, A., Castanas, E. Antiproliferative and apoptotic efects of selective phenolic acids on T47D human breast cancer cells: potential mechanisms of action. Breast Cancer Res. 2004, 6, R63-R74.
41. Kim, S.J., Kim, M.C., Um, J.Y., Hong, S.H. Te benefcial efect of vanillic acid on ulcerative colitis. Molecules 2010, 15, 7208-7217.
42. Itoh, A., Isoda, K., Kondoh, M., Kawase, M., Kobayashi, M., Tamesada, M., Yagi, K. Hepatoprotective efect of syringic acid and vanillic acid on concanavalin a-induced liver injury. Biol. Pharm. Bull. 2009, 32, 1215-1219.
43. Croford, L.J., Oates, J.C., McCune, W.J., Gupta, S., Kaplan, M.J., Catella-Lawson, F., Morrow, J.D., McDonagh, K.T., Schmaier, A.H. Trombosis in patients with connective tissue diseases treated with specifc cyclooxygenase 2 inhibitors. A report of four cases. Arthritis Rheum. 2000, 43, 1891-1896.
44. Meade, E.A., Smith, W.L., DeWitt, D.L. Diferential inhibition of prostaglandin endoperoxide synthase (cyclooxygenase) isozymes by aspirin and other non-steroidal anti-infammatory drugs. J. Biol. Chem. 1993, 268, 6610-6614. (Pubitemid 23099364)
45. Blackwell, T.S., Christman, J.W. Te role of nuclear factor-kappa B in cytokine gene regulation. Am. J. Respir. Cell Mol. Biol. 1997, 17, 3-9. (Pubitemid 127500814)
46. Tak, P.P., Firestein, G.S. NF-kappaB: a key role in infammatory diseases. J. Clin. Invest. 2001, 107, 7-11. (Pubitemid 32047405)
47. Kopp, E., Ghosh, S. Inhibition of NF-kappa B by sodium salicylate and aspirin. Science 1994, 265, 956-959.
48. Lappas, M., Permezel, M., Georgiou, H.M., Rice, G.E. Nuclear factor kappa B regulation of proinfammatory cytokines in human gestational tissues in vitro. Biol. Reprod. 2002, 67, 668-673. (Pubitemid 34803959)
49. Stark, L.A., Din, F.V., Zwacka, R.M., Dunlop, M.G. Aspirin-induced activation of the NF-kappaB signaling pathway: a novel mechanism for aspirin-mediated apoptosis in colon cancer cells. FASEB J. 2001, 15, 1273-1275.
50. Kuida, K., Lippke, J.A., Ku, G., Harding, M.W., Livingston, D.J., Su, M.S., Flavell, R.A. Altered cytokine export and apoptosis in mice defcient in interleukin-1 beta converting enzyme. Science 1995, 267, 2000-2003.
51. Chin, A.I., Dempsey, P.W., Bruhn, K., Miller, J.F., Xu, Y., Cheng, G. Involvement of receptor-interacting protein 2 in innate and adaptive immune responses. Nature 2002, 416, 190-194. (Pubitemid 34246478)
52. Kobayashi, K., Inohara, N., Hernandez, L.D., Galán, J.E., Núñez, G., Janeway, C.A., Medzhitov, R., Flavell, R.A. RICK/Rip2/CARDIAK mediates signalling for receptors of the innate and adaptive immune systems. Nature 2002, 416, 194-199. (Pubitemid 34246479)